Share price
₹73.55 latest close · +20.6% over the last 90 sessions
52-week range ₹58.10 to ₹105.00 · 1-year volatility 65.2%
How rough has the ride been?
Drawdown from peak
Largest drawdowns
-41.7% (2026-04 peak to 2026-06 low, not yet recovered)
-38.9% (2025-12 peak to 2026-03 low, recovered 2026-04)
Where does it rank among Health Services peers?
Each cell is the company's percentile rank among its Health Services peers (non-financial companies) that month.
Darker is better-ranked.
Rows marked ↓ are inverted (lower debt, shorter cash cycle and a lower P/E rank higher).
Where it ranks today
- ROCE72nd
- Debt/equity ↓89th
- Cash cycle ↓96th
- P/E ↓88th
Rank history
Percentiles use today's listed companies in the sector and need at least 5 peers with a value; grey cells have too few.
ROE is computed from net profit and book value where the source does not report it.
The Health Services sector page Watch it move against Health Services in the Observatory
What is the price implying?
At a P/E of 25.7x, the price would imply about 18.2%/yr earnings growth for 10 years under the same assumptions, but it is not ranked.
Fewer than six years of annual earnings are available, which is too little to measure delivered growth.
“Implied growth” is what the current price would require under our stated assumptions, not what we expect.
What prices imply across Health Services The market-wide Expectations lists
Key figures
- Share Priceclose 9 Nov
- ₹73.55
- P/E
- 18.8x
- ROCE
- 19.4%
- Market Cap
- ₹92 cr
- Revenue (TTM)
- ₹32 cr
- P/S
- 2.9x
- P/B
- 1.9x
- ROE
- 9.8%
- Debt / Equity
- 0.1x
- Promoter Holding
- 66.7%
52-week range
Price risk
Balance sheet & cash
Are profits backed by cash?
Other income reliance10%Within range
Other income as a share of pre-tax profit (trailing twelve months): 9.8%. Bands: below 15%, 15% to 35%, above 35%.
Tax rate—Not enough data
Not enough reported data to compute this.
Cash conversion1.10xWithin range
Operating cash flow divided by net profit over the last three fiscal years: 1.10x (cash from operations ₹13.7 cr, net profit ₹12.5 cr). Bands: 0.8x and above, 0.5x to 0.8x, below 0.5x.
Free cash flow1 of 3 yrsBeyond threshold
Fiscal years with positive free cash flow in the last 3: 1. Bands: at least 80% of years, 40% to 80%, below 40%.
Receivable days vs history—Not enough data
Not enough reported data to compute this.
Capital work in progress0% of fixed assetsWithin range
Capital work-in-progress is 0% of fixed assets. Bands: not rising or up to 30%; rising for three years and above 30%; rising and above 60%.
Payable days—Not enough data
Not enough reported data to compute this.
Tap a check to see how it is measured
How to read this
Each check is a named rule with fixed thresholds, not a score. Annual statements are the latest restated figures, so a past year may differ from what was originally reported.
What changed?
4 events since Mar '26
- JunPriceFell 42% from the Apr 2026 peak to the Jun 2026 low.
- JunPeer rankSlipped to the 2nd quartile of Health Services on ROCE (from the top quartile).
- AprPriceRegained the 2025-12 peak, 1 month after the low.
- MarPriceFell 39% from the Dec 2025 peak to the Mar 2026 low.
Events are generated from the data by fixed rules.
The month shown is when the change became visible in the reported figures, assuming a 60-day lag after each quarter end; it is not an announcement date.
Where price and fundamentals disagree, market-wide Rewind the whole market to any month
Monthly history12 months · 2025-12 to 2026-11
| Month | P/E | Revenue (TTM) | ROE | ROCE | Debt / Equity |
|---|---|---|---|---|---|
| 2026-11 | 18.8x | ₹32 cr | 9.8% | 19.4% | 0.1x |
| 2026-10 | 16.5x | ₹32 cr | 9.8% | 19.4% | 0.1x |
| 2026-09 | 17.3x | ₹32 cr | 9.8% | 19.4% | 0.1x |
| 2026-08 | 17.5x | ₹32 cr | 9.8% | 19.4% | 0.1x |
| 2026-07 | 17.4x | ₹32 cr | 9.8% | 19.4% | 0.1x |
| 2026-06 | 17.1x | ₹32 cr | 9.8% | 19.4% | 0.1x |
| 2026-05 | 11.3x | ₹30 cr | 36.0% | 45.0% | 0.3x |
| 2026-04 | 17.2x | ₹30 cr | 36.0% | 45.0% | 0.3x |
| 2026-03 | 10.8x | ₹30 cr | 36.0% | 45.0% | 0.3x |
| 2026-02 | 10.7x | ₹30 cr | 36.0% | 45.0% | 0.3x |
| 2026-01 | 11.1x | ₹30 cr | 36.0% | 45.0% | 0.3x |
| 2025-12 | 13.6x | ₹30 cr | 36.0% | 45.0% | 0.3x |